# Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520)

> **NCT01852812** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 87 (actual)

## Conditions studied

- Perennial Allergic Rhinitis

## Interventions

- **DRUG:** Montelukast Oral Granules (OG)
- **DRUG:** Montelukast Chewable Tablets (CT)

## Key facts

- **NCT ID:** NCT01852812
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-07
- **Primary completion:** 2013-12-24
- **Final completion:** 2013-12-24
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2024-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01852812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01852812, "Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01852812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*